Plasma levels of plasminogen, fibrinogen and plasmin non-diabetic and smoker patients with coronary artery disease
Medical Journal of Tabriz University of Medical Sciences and Health Services. 2017; 39 (1): 24-31
en Persa
| IMEMR
| ID: emr-188666
ABSTRACT
Background:
Coronary morbidity. It is characterized by the activation and aggregation of the platelet, thrombus formation and myocardial infarction. During recent years, many epidemiological studies on risk factors of CAD have been performed which are fibrinogen, lipoprotein [a], and hemocystein as new CAD risk factors. The aim of the present study was to evaluate of plasminogen., fibrinogen and plasmin [PAP] levels in plasma including in patients of non-diabetic and smoker as the hemostatic parameters and their association with CAD to prevent progression of disease
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Plasminógeno
/
Trombosis Coronaria
/
Fibrinógenos Anormales
/
Morbilidad
/
Aterosclerosis
/
Fumadores
Límite:
Humanos
Idioma:
Persa
Revista:
Med. J. Tabriz Univ. Med. Sci. Health Serv.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS